| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| TTC27 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN409016 | 1 kit | ORIGENE TECHNOLOGIES |
| TTC32 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN409334 | 1 kit | ORIGENE TECHNOLOGIES |
| TTC25 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN409614 | 1 kit | ORIGENE TECHNOLOGIES |
| Staufen, RNA binding protein, homolog 1 (Drosophila) (STAU1), transcript variant T5 from ORIGENE TECHNOLOGIES | LY421948 | 100 ug | ORIGENE TECHNOLOGIES |
| STAU1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN408387 | 1 kit | ORIGENE TECHNOLOGIES |
| STAU2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN418179 | 1 kit | ORIGENE TECHNOLOGIES |
| Stau1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516850 | 1 kit | ORIGENE TECHNOLOGIES |
| Stau2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516851 | 1 kit | ORIGENE TECHNOLOGIES |
| STAU1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH308387 | 10 ug | ORIGENE TECHNOLOGIES |
| STBD1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN404719 | 1 kit | ORIGENE TECHNOLOGIES |
| Stbd1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516852 | 1 kit | ORIGENE TECHNOLOGIES |
| ST6 beta-galactosamide alpha-2, 6-sialyltranferase 1 (ST6GAL1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY403548 | 100 ug | ORIGENE TECHNOLOGIES |
| ST6 beta-galactosamide alpha-2, 6-sialyltranferase 1 (ST6GAL1), transcript variant 3 from ORIGENE TECHNOLOGIES | LY403549 | 100 ug | ORIGENE TECHNOLOGIES |
| ST6 beta-galactosamide alpha-2, 6-sialyltranferase 1 (ST6GAL1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY418930 | 100 ug | ORIGENE TECHNOLOGIES |
| ST3 beta-galactoside alpha-2, 3-sialyltransferase 2 (ST3GAL2) from ORIGENE TECHNOLOGIES | LY416319 | 100 ug | ORIGENE TECHNOLOGIES |
| ST3 beta-galactoside alpha-2, 3-sialyltransferase 4 (ST3GAL4) from ORIGENE TECHNOLOGIES | LY416756 | 100 ug | ORIGENE TECHNOLOGIES |
| ST3 beta-galactoside alpha-2, 3-sialyltransferase 6 (ST3GAL6) from ORIGENE TECHNOLOGIES | LY416864 | 100 ug | ORIGENE TECHNOLOGIES |
| ST3 beta-galactoside alpha-2, 3-sialyltransferase 1 (ST3GAL1), transcript variant 1 from ORIGENE TECHNOLOGIES | LY418931 | 100 ug | ORIGENE TECHNOLOGIES |
| ST3 beta-galactoside alpha-2, 3-sialyltransferase 3 (ST3GAL3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY430415 | 100 ug | ORIGENE TECHNOLOGIES |
| ST3 beta-galactoside alpha-2, 3-sialyltransferase 1 (ST3GAL1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY403550 | 100 ug | ORIGENE TECHNOLOGIES |
| ST3 beta-galactoside alpha-2, 3-sialyltransferase 3 (ST3GAL3), transcript variant 1 from ORIGENE TECHNOLOGIES | LY406357 | 100 ug | ORIGENE TECHNOLOGIES |
| ST3 beta-galactoside alpha-2, 3-sialyltransferase 3 (ST3GAL3), transcript variant 10 from ORIGENE TECHNOLOGIES | LY401890 | 100 ug | ORIGENE TECHNOLOGIES |
| ST3 beta-galactoside alpha-2, 3-sialyltransferase 3 (ST3GAL3), transcript variant 4 from ORIGENE TECHNOLOGIES | LY406360 | 100 ug | ORIGENE TECHNOLOGIES |
| ST3 beta-galactoside alpha-2, 3-sialyltransferase 3 (ST3GAL3), transcript variant 4 from ORIGENE TECHNOLOGIES | LY430417 | 100 ug | ORIGENE TECHNOLOGIES |
| ST3 beta-galactoside alpha-2, 3-sialyltransferase 3 (ST3GAL3), transcript variant 7 from ORIGENE TECHNOLOGIES | LY406363 | 100 ug | ORIGENE TECHNOLOGIES |
| ST3 beta-galactoside alpha-2, 3-sialyltransferase 3 (ST3GAL3), transcript variant 7 from ORIGENE TECHNOLOGIES | LY430420 | 100 ug | ORIGENE TECHNOLOGIES |
| ST3 beta-galactoside alpha-2, 3-sialyltransferase 5 (ST3GAL5), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401284 | 100 ug | ORIGENE TECHNOLOGIES |
| ST3 beta-galactoside alpha-2, 3-sialyltransferase 5 (ST3GAL5), transcript variant 2 from ORIGENE TECHNOLOGIES | LY420902 | 100 ug | ORIGENE TECHNOLOGIES |
| Human Lymph node; Granuloma of lymph node from ORIGENE TECHNOLOGIES | CS631695 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lymph node; Hyperplasia of lymph node from ORIGENE TECHNOLOGIES | CS548209 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lymph node; Hyperplasia of lymph node, atypical from ORIGENE TECHNOLOGIES | CS606293 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lymph node; Inflammation of lymph node, chronic from ORIGENE TECHNOLOGIES | CS603349 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lymph node; Inflammation of lymph node, chronic from ORIGENE TECHNOLOGIES | CS603350 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lymph node; Lymphadenitis from ORIGENE TECHNOLOGIES | CS804765 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lymph node; Lymphadenitis from ORIGENE TECHNOLOGIES | CS617685 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lymph node; Lymphadenitis from ORIGENE TECHNOLOGIES | CS617686 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lymph node; Lymphadenitis from ORIGENE TECHNOLOGIES | CS617687 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lymph node; Lymphadenitis from ORIGENE TECHNOLOGIES | CS617688 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lymph node; Lymphadenitis from ORIGENE TECHNOLOGIES | CS617689 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lymph node; Lymphadenitis from ORIGENE TECHNOLOGIES | CS617690 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lymph node; Lymphadenitis, necrotizing from ORIGENE TECHNOLOGIES | CS702992 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lymph node; Lymphadenitis, necrotizing from ORIGENE TECHNOLOGIES | CS510228 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lymph node; Lymphadenitis, necrotizing from ORIGENE TECHNOLOGIES | CS510232 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lymph node; Lymphadenitis, necrotizing from ORIGENE TECHNOLOGIES | CS536230 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lymph node; Lymphadenopathy, dermatopathic from ORIGENE TECHNOLOGIES | CS710964 | 5x5um | ORIGENE TECHNOLOGIES |
| Human Lymph node; Lymphoma, follicular (protein lysate) from ORIGENE TECHNOLOGIES | CP565757 | 150 ug | ORIGENE TECHNOLOGIES |
| Human Lymph node; Lymphoma, follicular (protein lysate) from ORIGENE TECHNOLOGIES | CP565795 | 150 ug | ORIGENE TECHNOLOGIES |
| Human Lymph node; Lymphoma, follicular (protein lysate) from ORIGENE TECHNOLOGIES | CP565818 | 150 ug | ORIGENE TECHNOLOGIES |
| Human Lymph node; Lymphoma, follicular (protein lysate) from ORIGENE TECHNOLOGIES | CP565850 | 150 ug | ORIGENE TECHNOLOGIES |
| Human Lymph node; Lymphoma, follicular (protein lysate) from ORIGENE TECHNOLOGIES | CP565851 | 150 ug | ORIGENE TECHNOLOGIES |